Sarah Hull1,2, Gavin Arno1,2, Graham E Holder1,2, Vincent Plagnol3, Keith Gomez4, Ri Liesner5,6, Andrew R Webster1,2, Anthony T Moore1,2,7. 1. University College London Institute of Ophthalmology, London, UK. 2. Moorfields Eye Hospital, London, UK. 3. University College London Genetics Institute, London, UK. 4. Haematology Department, Royal Free London NHS Foundation Trust, London, UK. 5. Haematology Department, Great Ormond Street Hospital for Children NHS Trust, London, UK. 6. Haematology Department, University College London Hospitals, London, UK. 7. San Francisco Medical Centre, University of California, San Francisco, California, USA.
Abstract
BACKGROUND: Hermansky-Pudlak syndrome (HPS) may present to the ophthalmologist with signs suggestive of oculocutaneous albinism. Consideration of HPS as a differential diagnosis is important due to its potential systemic complications. HPS6 is a rarely reported subtype. METHODS: Three patients from two families underwent clinical examination, imaging and targeted systemic investigations. Electrophysiology with visual-evoked potentials (VEPs) was performed in both children of family 1. Whole exome sequencing (WES) was performed on the proband of family 1. Bidirectional Sanger sequencing of the single exon and intron-exon boundaries of HPS6 was performed on all affected patients and segregation confirmed in available relatives. RESULTS: Two siblings presented in infancy with nystagmus and reduced vision. They were initially diagnosed with isolated foveal hypoplasia with no aberrant chiasmal misrouting on VEPs. WES performed in the proband when 10 years of age identified a novel homozygous missense variant in HPS6 and further questioning elicited a history of nose bleeds and mild bruising. Segregation supported causality of this variant in the affected younger sibling. In the third unrelated patient, an initial diagnosis of ocular albinism was made at 3 months with HPS only diagnosed at 26 years. Biallelic, truncating mutations in HPS6 were identified by candidate Sanger sequencing and included a novel variant. Abnormal platelet function consistent with HPS was confirmed in all patients. CONCLUSIONS: The diagnosis of HPS in all patients was delayed due to a mild systemic phenotype. Next-generation sequencing can aid diagnosis of syndromic conditions with important consequences for preventing morbidity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND:Hermansky-Pudlak syndrome (HPS) may present to the ophthalmologist with signs suggestive of oculocutaneous albinism. Consideration of HPS as a differential diagnosis is important due to its potential systemic complications. HPS6 is a rarely reported subtype. METHODS: Three patients from two families underwent clinical examination, imaging and targeted systemic investigations. Electrophysiology with visual-evoked potentials (VEPs) was performed in both children of family 1. Whole exome sequencing (WES) was performed on the proband of family 1. Bidirectional Sanger sequencing of the single exon and intron-exon boundaries of HPS6 was performed on all affected patients and segregation confirmed in available relatives. RESULTS: Two siblings presented in infancy with nystagmus and reduced vision. They were initially diagnosed with isolated foveal hypoplasia with no aberrant chiasmal misrouting on VEPs. WES performed in the proband when 10 years of age identified a novel homozygous missense variant in HPS6 and further questioning elicited a history of nose bleeds and mild bruising. Segregation supported causality of this variant in the affected younger sibling. In the third unrelated patient, an initial diagnosis of ocular albinism was made at 3 months with HPS only diagnosed at 26 years. Biallelic, truncating mutations in HPS6 were identified by candidate Sanger sequencing and included a novel variant. Abnormal platelet function consistent with HPS was confirmed in all patients. CONCLUSIONS: The diagnosis of HPS in all patients was delayed due to a mild systemic phenotype. Next-generation sequencing can aid diagnosis of syndromic conditions with important consequences for preventing morbidity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
Child health (paediatrics); Diagnostic tests/Investigation; Electrophysiology; Genetics; Retina
Authors: Chen G Han; Kevin J O'Brien; Lea M Coon; Julie A Majerus; Laryssa A Huryn; Sara G Haroutunian; Nagabhishek Moka; Wendy J Introne; Ellen Macnamara; William A Gahl; May Christine V Malicdan; Dong Chen; Koyamangalath Krishnan; Bernadette R Gochuico Journal: Am J Med Genet A Date: 2018-10-04 Impact factor: 2.802
Authors: J E Self; M J Dunn; J T Erichsen; I Gottlob; H J Griffiths; C Harris; H Lee; J Owen; J Sanders; F Shawkat; M Theodorou; J P Whittle Journal: Eye (Lond) Date: 2020-01-09 Impact factor: 3.775
Authors: Marjan Huizing; May C V Malicdan; Jennifer A Wang; Hadass Pri-Chen; Richard A Hess; Roxanne Fischer; Kevin J O'Brien; Melissa A Merideth; William A Gahl; Bernadette R Gochuico Journal: Hum Mutat Date: 2020-01-23 Impact factor: 4.700